Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E R Peskind

Showing results (71-80 of 77) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 77 results.
Neurobiology of Disease|June 17, 2017
Blast-related disinhibition and risk seeking in mice and combat Veterans: Potential role for dysfunctional phasic dopamine releaseA G Schindler, J S Meabon, K F Pagulayan, et al.
Alzheimer Disease and Associated Disorders|January 23, 1998
Clinicopathologic correlations of soluble amyloid beta-protein precursor in cerebrospinal fluid in patients with Alzheimer disease and controlsE R Peskind, J Leverenz, M R Farlow, et al.
Neuroscience|January 19, 2016
Blast exposure causes dynamic microglial/macrophage responses and microdomains of brain microvessel dysfunctionB R Huber, J S Meabon, Z S Hoffer, et al.
The Journal of Prevention of Alzheimer'S Disease|October 25, 2022
Adjudicating Mild Cognitive Impairment Due to Alzheimer's Disease as a Novel Endpoint Event in the TOMMORROW Prevention Clinical TrialL S Schneider, D A Bennett, M R Farlow, et al.
Neurobiology of Aging|January 4, 2011
Amyloid precursor protein (APP) processing genes and cerebrospinal fluid APP cleavage product levels in Alzheimer's diseaseL M Bekris, N M Galloway, S Millard, et al.
Investigative Ophthalmology & Visual Science|June 30, 2001
Glucocorticoid induction of the glaucoma gene MYOC in human and monkey trabecular meshwork cells and tissuesA F Clark, H T Steely, J E Dickerson, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 8, 2009
Neuroprotective natural antibodies to assemblies of amyloidogenic peptides decrease with normal aging and advancing Alzheimer's diseaseM Britschgi, C E Olin, H T Johns, et al.
Pageof 8

Showing results (71-80 of 77) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 77 results.
Neurobiology of Disease|June 17, 2017
Blast-related disinhibition and risk seeking in mice and combat Veterans: Potential role for dysfunctional phasic dopamine releaseA G Schindler, J S Meabon, K F Pagulayan, et al.
Alzheimer Disease and Associated Disorders|January 23, 1998
Clinicopathologic correlations of soluble amyloid beta-protein precursor in cerebrospinal fluid in patients with Alzheimer disease and controlsE R Peskind, J Leverenz, M R Farlow, et al.
Neuroscience|January 19, 2016
Blast exposure causes dynamic microglial/macrophage responses and microdomains of brain microvessel dysfunctionB R Huber, J S Meabon, Z S Hoffer, et al.
The Journal of Prevention of Alzheimer'S Disease|October 25, 2022
Adjudicating Mild Cognitive Impairment Due to Alzheimer's Disease as a Novel Endpoint Event in the TOMMORROW Prevention Clinical TrialL S Schneider, D A Bennett, M R Farlow, et al.
Neurobiology of Aging|January 4, 2011
Amyloid precursor protein (APP) processing genes and cerebrospinal fluid APP cleavage product levels in Alzheimer's diseaseL M Bekris, N M Galloway, S Millard, et al.
Investigative Ophthalmology & Visual Science|June 30, 2001
Glucocorticoid induction of the glaucoma gene MYOC in human and monkey trabecular meshwork cells and tissuesA F Clark, H T Steely, J E Dickerson, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 8, 2009
Neuroprotective natural antibodies to assemblies of amyloidogenic peptides decrease with normal aging and advancing Alzheimer's diseaseM Britschgi, C E Olin, H T Johns, et al.
Pageof 8